GB8824709D0 - Oral dosage forms of omega-3 polyunsaturated acids - Google Patents

Oral dosage forms of omega-3 polyunsaturated acids

Info

Publication number
GB8824709D0
GB8824709D0 GB8824709A GB8824709A GB8824709D0 GB 8824709 D0 GB8824709 D0 GB 8824709D0 GB 8824709 A GB8824709 A GB 8824709A GB 8824709 A GB8824709 A GB 8824709A GB 8824709 D0 GB8824709 D0 GB 8824709D0
Authority
GB
Grant status
Grant
Patent type
Prior art keywords
oral
dosage
forms
omega
polyunsaturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8824709A
Other versions
GB2223943A (en )
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tillotts Pharma AG
Original Assignee
Tillotts Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
GB8824709A 1988-10-21 1988-10-21 Oral dosage forms of omega-3 polyunsaturated acids Withdrawn GB8824709D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8824709A GB8824709D0 (en) 1988-10-21 1988-10-21 Oral dosage forms of omega-3 polyunsaturated acids

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8824709A GB8824709D0 (en) 1988-10-21 1988-10-21 Oral dosage forms of omega-3 polyunsaturated acids
CA 2000881 CA2000881A1 (en) 1988-10-21 1989-10-17 Oral dosage forms of omega-3 polyunsaturated acids
PCT/GB1989/001251 WO1990004391A1 (en) 1988-10-21 1989-10-20 Oral dosage forms of omega-3 polyunsaturated acids

Publications (2)

Publication Number Publication Date
GB8824709D0 true GB8824709D0 (en) 1988-11-30
GB2223943A true GB2223943A (en) 1990-04-25

Family

ID=10645593

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8824709A Withdrawn GB8824709D0 (en) 1988-10-21 1988-10-21 Oral dosage forms of omega-3 polyunsaturated acids

Country Status (3)

Country Link
CA (1) CA2000881A1 (en)
GB (1) GB8824709D0 (en)
WO (1) WO1990004391A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457130A (en) * 1989-03-20 1995-10-10 Cancer Research Campaign Technology Limited Eicosapentaenoic acid used to treat cachexia
GB8906369D0 (en) * 1989-03-20 1989-05-04 Tisdale Michael J Eicosapentaenoic acid
FR2663222A1 (en) * 1990-06-13 1991-12-20 Medgenix Group Sa Microcapsule oily liquid.
WO1992012711A1 (en) * 1991-01-24 1992-08-06 Martek Corporation Microbial oil mixtures and uses thereof
GB2300807B (en) * 1995-05-15 1999-08-18 Tillotts Pharma Ag Oral dosage forms of omega-3 polynunsaturated acids for the treatment of inflammatory bowel disease
GB9509764D0 (en) * 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
CA2240165A1 (en) * 1995-12-11 1997-06-19 Inholtra, Inc. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
US5840715A (en) * 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
GB9901809D0 (en) 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
US6451771B1 (en) 1999-02-12 2002-09-17 Nutramax Laboratories, Inc. Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
DE19930030B4 (en) * 1999-06-30 2004-02-19 Meduna Arzneimittel Gmbh CO-3-unsaturated fatty acids-containing oral dosage form
WO2002102364A1 (en) * 2001-06-18 2002-12-27 Yamada, Sachiko Pparg agonistic medicinal compositions
US20030144219A1 (en) * 2001-11-15 2003-07-31 Phinney Stephen Dodge Formulations and methods for treatment or amelioration of inflammatory conditions
EP2283838A3 (en) * 2002-09-27 2011-04-20 Martek Biosciences Corporation Docosahexaenoic acid for treating subclinical inflammation
JP2006519244A (en) * 2003-03-05 2006-08-24 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツングSolvay Pharmaceuticals GmbH The use of omega-3- fatty acids in the treatment of diabetic patients
US7759507B2 (en) 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
GB0428384D0 (en) * 2004-12-24 2005-02-02 Sla Pharma Ag Eicosapentaenoic acid
WO2006122123A3 (en) * 2005-05-09 2007-06-07 Bruce H Levin Methods of alleviating disorders and their associated pain
JP2009523414A (en) 2005-12-21 2009-06-25 ブルーディ、テクノロジー、ソシエダッド、リミターダBrudy Technology,S.L. dha to treat pathologies associated with oxidative cell damage, use of epa from epa or dha
CA2929998A1 (en) * 2008-12-31 2010-07-08 Raymond A. Miller Dietary supplements comprising activated fatty acids
KR20140007973A (en) 2009-02-10 2014-01-20 아마린 파마, 인크. Methods of treating hypertriglyceridemia
EP2424521A4 (en) 2009-04-29 2015-03-04 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
US20120100208A1 (en) 2009-04-29 2012-04-26 Amarin Pharma, Inc. Stable pharmaceutical composition and methods of using same
CA2772378A1 (en) 2009-06-15 2010-12-23 Amarin Pharma, Inc. Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
CN107050457A (en) 2012-01-06 2017-08-18 翁特拉制药公司 Dpa-enriched Compositions Of Omega-3 Polyunsaturated Fatty Acids In Free Acid Form
US9827219B2 (en) 2012-01-06 2017-11-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject
RU2645075C2 (en) 2012-05-07 2018-02-15 Омтера Фармасьютикалс, Инк. Compositions of statins and omega-3 fatty acids
WO2014005013A3 (en) 2012-06-29 2014-02-20 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US20170042947A1 (en) * 2014-04-25 2017-02-16 Yamada Bee Company, Inc. Unsaturated fatty acid absorption accelerator

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0141604B2 (en) * 1980-06-27 1989-09-06 Nippon Yushi Kk
EP0266323A1 (en) * 1986-09-29 1988-05-04 KabiVitrum AB Tablet containing gamma-linolenic acid, eicosa pentaenoic acid and/or docosahexaenoic acid, and method for its manufacturing

Also Published As

Publication number Publication date Type
CA2000881A1 (en) 1990-04-21 application
WO1990004391A1 (en) 1990-05-03 application
GB2223943A (en) 1990-04-25 application

Similar Documents

Publication Publication Date Title
GB2229363B (en) Eicosapentaenoic acid
JPS61284903A (en) Manufacture of resistor for resistance-contained plug
JPS6133649A (en) Production of denture floor and denture floor
JPS6289614A (en) Oral sanitary composition
JPS6251647A (en) Manufacture of fatty polyamine
JPS60190930A (en) Light quantity controller of medical machine
JPS63101321A (en) Ibuprofen-containing medicinal composition
JPS63214255A (en) Hyperthermia method using candle containing effective component
JPS5849312A (en) Medicine of dipyridamole for oral administration
JPS62179349A (en) Chewing gum formed into tablet
JPS6253111A (en) Floor wire intersecting apparatus
JPS63270911A (en) Plugging ring for nut
JPS6296409A (en) Plaque preventive oral composition
JPS60146871A (en) Resolution of bicyclic imino-alpha-carboxylic acid ester racemic body
JPS61140544A (en) Manufacture of fatty acid methyl ester
EP0284991A3 (en) Photopolymerizable dental composition
JPS6217416A (en) Manufacture of thread product
JPS6256426A (en) Medicinal composition for treating human malaria
JPS59101419A (en) Dental and oral sanitary medicine
JPS61286350A (en) Synthesis of fatty polyamine
JPS62277496A (en) Concentration of highly unsaturated fatty acid-containing triglyceride
JPS61220645A (en) Fixed partial denture and its production
JPS6219160A (en) Artificial tooth
JPS62113398A (en) Stroboscopic controller
JPS6440460A (en) Manufacture of quinolonecarboxylic acids

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)